Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1990 Sep;66(779):781–783. doi: 10.1136/pgmj.66.779.781

Ursodeoxycholic acid therapy in chronic active hepatitis.

M C Bateson 1
PMCID: PMC2426868  PMID: 2235818

Abstract

A 41 year old woman developed chronic active hepatitis with prominent cholestasis. She was treated with prednisolone over 3 years with symptomatic benefit and improvement in serum biochemistry. However, various steroid-related side effects were encountered and steatorrhoea eventually occurred with very troublesome nocturnal diarrhoea. Therapy with ursodeoxycholic acid 750 mg daily was started. Serum alanine aminotransferase and gamma-glutamyl transferase normalized for the first time since her illness began. Steatorrhoea was abolished. There was good control of symptoms as prednisolone therapy was gradually reduced. However, when prednisolone was completely withdrawn there was a prompt biochemical deterioration. Addition of low-dose azathioprine has maintained normal blood tests over 24 months without return of the original symptoms. There are no side effects of ursodeoxycholic acid in subjects without gallstones and this agent may be effective treatment for cholestatic liver disease.

Full text

PDF
781

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akashi Y., Miyazaki H., Yanagisawa J., Nakayama F. Bile acid metabolism in cirrhotic liver tissue--altered synthesis and impaired hepatic secretion. Clin Chim Acta. 1987 Sep 30;168(2):199–206. doi: 10.1016/0009-8981(87)90289-0. [DOI] [PubMed] [Google Scholar]
  2. Bateson M. C., Ross P. E., Diffey B. L. Ursodeoxycholic acid in primary biliary cirrhosis. Lancet. 1989 Apr 22;1(8643):898–899. doi: 10.1016/s0140-6736(89)92888-2. [DOI] [PubMed] [Google Scholar]
  3. Czaja A. J., Beaver S. J., Shiels M. T. Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen-negative chronic active hepatitis. Gastroenterology. 1987 Jan;92(1):215–219. doi: 10.1016/0016-5085(87)90862-6. [DOI] [PubMed] [Google Scholar]
  4. Hyams J. S., Ballow M., Leichtner A. M. Cyclosporine treatment of autoimmune chronic active hepatitis. Gastroenterology. 1987 Oct;93(4):890–893. doi: 10.1016/0016-5085(87)90454-9. [DOI] [PubMed] [Google Scholar]
  5. Leuschner U., Kurtz W. Treatment of primary biliary cirrhosis and cholestatic disorders with ursodeoxycholic acid. Lancet. 1987 Aug 29;2(8557):508–508. doi: 10.1016/s0140-6736(87)91812-5. [DOI] [PubMed] [Google Scholar]
  6. Leuschner U., Leuschner M., Sieratzki J., Kurtz W., Hübner K. Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study. Dig Dis Sci. 1985 Jul;30(7):642–649. doi: 10.1007/BF01308413. [DOI] [PubMed] [Google Scholar]
  7. Miyazaki K., Nakayama F., Koga A. Effect of chenodeoxycholic and ursodeoxycholic acids on isolated adult human hepatocytes. Dig Dis Sci. 1984 Dec;29(12):1123–1130. doi: 10.1007/BF01317087. [DOI] [PubMed] [Google Scholar]
  8. Palmer R. H. Bile acids, liver injury, and liver disease. Arch Intern Med. 1972 Oct;130(4):606–617. [PubMed] [Google Scholar]
  9. Podda M., Ghezzi C., Battezzati P. M., Bertolini E., Crosignani A., Petroni M. L., Zuin M. Ursodeoxycholic acid for chronic liver diseases. J Clin Gastroenterol. 1988;10 (Suppl 2):S25–S31. [PubMed] [Google Scholar]
  10. Poupon R., Chrétien Y., Poupon R. E., Ballet F., Calmus Y., Darnis F. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet. 1987 Apr 11;1(8537):834–836. doi: 10.1016/s0140-6736(87)91610-2. [DOI] [PubMed] [Google Scholar]
  11. Schaffner F. Autoimmune chronic active hepatitis: three decades of progress. Prog Liver Dis. 1986;8:485–503. [PubMed] [Google Scholar]
  12. Somayaji B. N., Paton A., Price J. H., Harris A. W., Flewett T. H. Norethisterone jaundice in two sisters. Br Med J. 1968 May 4;2(5600):281–283. doi: 10.1136/bmj.2.5600.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Stellon A. J., Keating J. J., Johnson P. J., McFarlane I. G., Williams R. Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal. Hepatology. 1988 Jul-Aug;8(4):781–784. doi: 10.1002/hep.1840080414. [DOI] [PubMed] [Google Scholar]
  14. Vogel W., Kathrein H., Judmaier G., Braunsteiner H. Deterioration of primary biliary cirrhosis during treatment with ursodeoxycholic acid. Lancet. 1988 May 21;1(8595):1163–1163. doi: 10.1016/s0140-6736(88)91974-5. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES